Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;23(2):316-23.
doi: 10.1158/1055-9965.EPI-13-0929. Epub 2013 Dec 2.

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes

Affiliations

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes

Mariana Chavez-Macgregor et al. Cancer Epidemiol Biomarkers Prev. 2014 Feb.

Abstract

Background: Differences in gene or protein expression patterns between breast cancers according to race/ethnicity and cancer subtype.

Methods: Transcriptional profiling was performed using Affymetrix HG-U133A platform in 376 patients and reverse phase protein array analysis (RPPA) was done for 177 proteins in 255 patients from a separate cohort. Unsupervised clustering was conducted, as well as supervised comparison by race and tumor subtype. Standard statistical methods, BRB-Array tools, and Ingenuity Pathways software packages were used to analyze the data.

Results: Median age was 50 years in both the cohorts. In the RPPA cohort, 54.5% of the tumors were hormone receptor-positive (HR-positive), 20.7% HER2-positive, and 24.71% triple-negative (TNBC). One hundred and forty-seven (57.6%), 47 (18.43%), and 46 (18.1%) of the patients were White, Hispanic, and Black, respectively. Unsupervised hierarchical clustering of the protein expression data showed no distinct clusters by race (P values were 0.492, 0.489, and 0.494 for the HR-positive, HER2-positive, and TNBC tumors respectively). In the gene expression cohort, 54.2% of the tumors were HR-positive, 16.5% HER2-positive, and 29.3% TNBC. Two hundred and sixteen (57.5%), 111 (29.52%), and 32 (8.52%) patients were White, Hispanic, and Black, respectively. No probe set with a false discovery rate (FDR) of <0.05 showed an association with race by breast cancer subtype; similar results were obtained using pathway and gene set enrichment analysis methods.

Conclusions: We did not detect a significant variation in RNA or protein expression comparing different race/ethnicity groups of women with breast cancer.

Impact: More research on the complex network of factors that result in outcomes differences among race/ethnicities is needed.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Unsupervised clustering analysis of 177 proteins showing no indication of an orderly pattern in races by breast cancer subtype. The row side bar color displays the race (White: red; Hispanic: blue; Black: black; Others: green)
Figure 2
Figure 2
Ingenuity Pathway Analysis (IPA) showing no obvious difference in pathway activation among races within breast cancer subtypes

References

    1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41. - PubMed
    1. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:714–36. - PMC - PubMed
    1. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18. - PubMed
    1. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168–83. - PubMed
    1. Siegel R, Naishandham D, Jemal A. Cancer Statistics for Hispanics/Latinos. CA Cancer J Clin. 2012;62:238–298. - PubMed

Publication types

MeSH terms